Osteopontin in Immune-mediated Diseases

Abstract

Since its initial identification as one of the genes most highly upregulated upon T-cell activation, osteopontin (or Eta-1, as it was designated then) has been demonstrated to have many roles in the regulation of the immune response on multiple levels. It contributes to the development of immune-mediated and inflammatory diseases, and it regulates the host response to infection. In some cases, the mechanisms of these effects have been elucidated, while other mechanistic functions of the protein remain obscure. The protein itself makes these analyses complex, since it binds to a series of different integrins, and in addition to its classically secreted form, an intracellular form of osteopontin has been identified, which participates in several aspects of immune regulation. In this review, we focus on the role of osteopontin in a series of immune-related diseases, particularly those where significant advances have been made in recent years: multiple sclerosis, rheumatoid arthritis, lupus and related diseases, Sjögren's disease, colitis, and 1 area of inflammatory pathology, alcoholic and nonalcoholic liver diseases. A recurring theme in these diseases is a link between osteopontin and pathogenic T cells, particularly T helper 17 cells, where osteopontin produced by dendritic cells supports IL-17 expression, contributing to pathology. In addition, a role for osteopontin in B-cell differentiation is becoming clear. In general, osteopontin contributes to pathology in these diseases, but there are examples where it has a protective role; deciphering the mechanisms underlying these differences and the specific receptors for osteopontin will be a research challenge for the future. Aside from its newly discovered role in the development of Sjögren's disease, the role of osteopontin in inflammatory conditions in the oral cavity is still poorly understood. Elucidation of this role will be of interest.

Osteopontin enhances multi-walled carbon nanotube-triggered lung fibrosis by promoting TGF-β1 activation and myofibroblast differentiation

“…As both a cytokine and an ECM protein, OPN regulates a range of physiologic and pathologic processes, such as inflammatory infiltration, tissue remodeling, bone remodeling, and cancer metastasis [21, 22]. OPN exhibits a high level of expression in wound healing and is highly induced during organ fibrosis in animal models with significant pro-fibrotic activities [23–34].…”

The elevated level of osteopontin in patients with pemphigus vulgaris: A cytokine‐like protein with a therapeutic potential

“…High levels of OPN can be detected in several autoimmune diseases (Rittling & Singh, ) such as SLE (Kaleta, ), MS, asthma (Akelma, Cizmeci, Kanburoglu, et al, ), RA, and Crohn's disease (Rittling & Singh, ); however, the role of OPN in pemphigus has remained elusive.…”

CSF-PR 2.0: An Interactive Literature Guide to Quantitative Cerebrospinal Fluid Mass Spectrometry Data from Neurodegenerative Disorders

“…However, it could have potential as a disease status marker for MS after treatment (with Lamotrigine). Osteopontin is a regulator of inflammation and immunity and has indeed been suggested to have a role in immune mediated diseases (46), but it is also implicated in fibrosis, tumorigenesis, and cancer metastasis (47).…”